Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Acquired by BDF Gestion

BDF Gestion grew its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 79.9% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 12,774 shares of the medical equipment provider's stock after buying an additional 5,673 shares during the quarter. BDF Gestion's holdings in Intuitive Surgical were worth $6,327,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Onefund LLC raised its stake in Intuitive Surgical by 1.9% in the 4th quarter. Onefund LLC now owns 947 shares of the medical equipment provider's stock valued at $494,000 after purchasing an additional 18 shares during the last quarter. AlphaCore Capital LLC boosted its position in shares of Intuitive Surgical by 4.2% during the fourth quarter. AlphaCore Capital LLC now owns 451 shares of the medical equipment provider's stock worth $235,000 after buying an additional 18 shares during the period. Parkside Financial Bank & Trust grew its stake in shares of Intuitive Surgical by 2.6% in the fourth quarter. Parkside Financial Bank & Trust now owns 747 shares of the medical equipment provider's stock worth $390,000 after acquiring an additional 19 shares in the last quarter. Accredited Investors Inc. lifted its stake in Intuitive Surgical by 1.9% in the fourth quarter. Accredited Investors Inc. now owns 1,040 shares of the medical equipment provider's stock worth $543,000 after acquiring an additional 19 shares during the last quarter. Finally, Second Line Capital LLC lifted its stake in Intuitive Surgical by 3.4% in the fourth quarter. Second Line Capital LLC now owns 578 shares of the medical equipment provider's stock worth $302,000 after acquiring an additional 19 shares during the last quarter. Institutional investors own 83.64% of the company's stock.

Analyst Upgrades and Downgrades

ISRG has been the topic of a number of analyst reports. Barclays reduced their price objective on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a report on Thursday, April 24th. BTIG Research set a $560.00 price target on Intuitive Surgical and gave the stock a "buy" rating in a report on Monday, April 14th. Robert W. Baird lowered their price objective on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. Truist Financial reduced their price target on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating for the company in a research report on Wednesday, April 23rd. Finally, Evercore ISI decreased their price objective on shares of Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating for the company in a research note on Wednesday, April 23rd. One analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $588.95.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Robert Desantis sold 188 shares of the firm's stock in a transaction that occurred on Monday, April 28th. The stock was sold at an average price of $515.91, for a total value of $96,991.08. Following the completion of the sale, the executive vice president now directly owns 5,224 shares of the company's stock, valued at $2,695,113.84. This trade represents a 3.47% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Mark Brosius sold 215 shares of the company's stock in a transaction on Monday, June 2nd. The stock was sold at an average price of $549.06, for a total value of $118,047.90. Following the transaction, the senior vice president now directly owns 1,768 shares in the company, valued at $970,738.08. This represents a 10.84% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 4,998 shares of company stock valued at $2,611,577. 0.70% of the stock is owned by corporate insiders.

Intuitive Surgical Stock Up 1.3%

Shares of NASDAQ ISRG traded up $6.86 during mid-day trading on Monday, hitting $519.04. 1,513,774 shares of the company were exchanged, compared to its average volume of 1,675,177. The stock has a 50 day simple moving average of $526.57 and a 200-day simple moving average of $538.46. Intuitive Surgical, Inc. has a 1-year low of $413.82 and a 1-year high of $616.00. The firm has a market cap of $186.03 billion, a price-to-earnings ratio of 80.97, a price-to-earnings-growth ratio of 5.85 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. The business had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. During the same period in the previous year, the business posted $1.50 earnings per share. Analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.